Company / Operating Income
NovoCure Ltd Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$153.8M
FY2025
5-year range
-$232.9M / -$44.3M
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#131 of 151
Health Care
What the data says
NovoCure Ltd's operating income of -$154M is lower than 87% of companies in the Health Care sector (FY2025). Improved from -$233M to -$154M over the past 2 years.
Based on SEC 10-K filings.
-$154M in FY2025.
Improved from -$233M to -$154M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 151This company -$153.8M Sector average $716.7M
▼
-121.5% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 9.8% year-over-year.
- Ranks #131 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$153.8M | +9.8% |
| FY2024 | -$170.5M | +26.8% |
| FY2023 | -$232.9M | -160.1% |
| FY2022 | -$89.5M | -101.9% |
| FY2021 | -$44.3M | -245.8% |
| FY2020 | $30.4M | +3426.1% |
| FY2019 | -$914.0K | +97.3% |
| FY2018 | -$33.7M | +14.4% |
| FY2017 | -$39.3M | +65.9% |
| FY2016 | -$115.3M | -10.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026